Jack W. Singer, EVP, Global Medical Affairs at CTI BIOPHARMA CORP (CTIC), sold 15,000 shares at $2.04 ($31K) on 2015-06-26, disclosed to the SEC on 2015-06-26.
Scheduled sale ($31k) by EVP, Global Medical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.04 | 400 | $816 | 2.6% |
| 2 | $2.05 | 400 | $820 | 2.6% |
| 3 | $2.05 | 1,200 | $2K | 7.9% |
| 4 | $2.06 | 100 | $206 | 0.7% |
| 5 | $2.06 | 3,500 | $7K | 23.2% |
| 6 | $2.07 | 4,300 |
| $9K |
| 28.7% |
| 7 | $2.07 | 2,200 | $5K | 14.7% |
| 8 | $2.08 | 200 | $416 | 1.3% |
| 9 | $2.08 | 500 | $1K | 3.3% |
| 10 | $2.09 | 100 | $209 | 0.7% |
| 11 | $2.10 | 1,200 | $3K | 8.1% |
| 12 | $2.11 | 700 | $1K | 4.8% |
| 13 | $2.11 | 200 | $422 | 1.4% |
| Total | $2.07 avg | 15,000 | $31K | 100% |
| Filing → |
| CTIC | SELL | 2015-12-18 | $18K | — | Filing → |
| CTIC | SELL | 2015-11-30 | $18K | — | Filing → |
| CTIC | SELL | 2015-10-23 | $24K | — | Filing → |